株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

腎代替療法の世界市場の分析と予測

Global Renal Replacement Therapy Market Research and Forecast, 2018-2023

発行 Orion Market Research Pvt Ltd 商品コード 785689
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
腎代替療法の世界市場の分析と予測 Global Renal Replacement Therapy Market Research and Forecast, 2018-2023
出版日: 2019年01月15日 ページ情報: 英文
概要

当レポートでは、世界の腎臓代替療法市場の現状と見通しについて分析し、疾患の概要や主な治療法、市場の基本構造、外部からのマクロ的・ミクロ的影響、主な促進・抑制要因、世界全体および地域別の市場動向の見通し (今後6年間分)、セグメント別 (治療法、エンドユーザーなど)の詳細動向、最新の市場競争状況、主要企業のプロファイルなどを調査しております。

第1章 分析概要

第2章 市場の概要と考察

  • 定義
  • アナリストの見解と現在の市場動向
    • 分析のポイント
    • 提言
    • 結論
  • 世界各国の規制状況

第3章 市場の決定要因

  • 促進要因
  • 抑制要因
  • 市場機会

第4章 市場区分

  • 世界の腎代替療法市場:治療法の種類別
    • 透析
      • 血液透析
      • 腹膜透析
    • 血液濾過
    • 血液濾過透析
    • 腎臓移植
  • 世界の腎代替療法市場:経路別
    • 動静脈
    • 静静脈
  • 世界の腎代替療法市場:エンドユーザー別
    • 病院・クリニック
    • 研究機関

第5章 競争環境

  • 主要企業の分析
  • 主要戦略の分析

第6章 地域別分析

  • 北米 (米国、カナダ)
  • 欧州 (英国、ドイツ、スペイン、フランス、イタリアなど)
  • アジア太平洋地域 (インド、中国、日本など)
  • 他の国々 (RoW)

第7章 企業プロファイル

  • 旭化成
  • AngioDynamics, Inc.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • C. R. Bard, Inc.
  • CryoLife, Inc.
  • DaVita Inc.
  • Diaverum Deutschland GmbH
  • Fresenius Medical Care AG & Co. KGaA
  • Hebei Ziweishan Pharmaceutical Co., Ltd.
  • Isopure Corp.
  • JMS Co., Ltd.
  • 川澄化学工業
  • Medivators Inc.
  • Medtronic PLC
  • Navilyst Medical, Inc.
  • 日機装
  • NxStage Medical, Inc.
  • Renacon Pharma Ltd.
  • Rockwell Medical, Inc.
図表

List of Tables

  • TABLE # 1 GLOBAL RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPY TYPE, 2017-2023($ MILLION)
  • TABLE # 2 GLOBAL DIALYSIS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 3 GLOBAL HEMOFILTRATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 4 GLOBAL HEMODIAFILTRATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 5 GLOBAL KIDNEY TRANSPLANTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 6 GLOBAL RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ROUTE, 2017-2023($ MILLION)
  • TABLE # 7 GLOBAL ARTERIOVENOUS ROUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 8 GLOBAL VENOVENOUS ROUTE MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 9 GLOBAL RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023($ MILLION)
  • TABLE # 10 GLOBAL HOSPITALS AND CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 11 GLOBAL RESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2017-2023($ MILLION)
  • TABLE # 12 NORTH AMERICA RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
  • TABLE # 13 NORTH AMERICA RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPY TYPE, 2017-2023($ MILLION)
  • TABLE # 14 NORTH AMERICA RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ROUTE, 2017-2023($ MILLION)
  • TABLE # 15 NORTH AMERICA RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023($ MILLION)
  • TABLE # 16 EUROPE RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
  • TABLE # 17 EUROPE RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPY TYPE, 2017-2023($ MILLION)
  • TABLE # 18 EUROPE RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ROUTE, 2017-2023($ MILLION)
  • TABLE # 19 EUROPE RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023($ MILLION)
  • TABLE # 20 ASIA-PACIFIC RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2017-2023($ MILLION)
  • TABLE # 21 ASIA-PACIFIC RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPY TYPE, 2017-2023($ MILLION)
  • TABLE # 22 ASIA-PACIFIC RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ROUTE, 2017-2023($ MILLION)
  • TABLE # 23 ASIA PACIFIC RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023($ MILLION)
  • TABLE # 24 REST OF THE WORLD RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY THERAPY TYPE, 2017-2023($ MILLION)
  • TABLE # 25 REST OF THE WORLD RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY ROUTE, 2017-2023($ MILLION)
  • TABLE # 26 REST OF THE WORLD RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS BY END-USER, 2017-2023($ MILLION)

List of Figures

  • FIGURE # 1 GLOBAL RENAL REPLACEMENT THERAPY MARKET SHARE BY THERAPY TYPE, 2017 VS 2023(%)
  • FIGURE # 2 GLOBAL RENAL REPLACEMENT THERAPY MARKET SHARE BY ROUTE, 2017 VS 2023(%)
  • FIGURE # 3 GLOBAL RENAL REPLACEMENT THERAPY MARKET SHARE BY END-USER, 2017 VS 2023(%)
  • FIGURE # 4 GLOBAL RENAL REPLACEMENT THERAPY MARKET SHARE BY GEOGRAPHY, 2017 VS 2023(%)
  • FIGURE # 5 US RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 6 CANADA RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 7 UK RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 8 GERMANY RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 9 SPAIN RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 10 FRANCE RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 11 ITALY RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 12 ROE RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 13 INDIA RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 14 CHINA RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 15 JAPAN RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 16 REST OF ASIA-PACIFIC RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
  • FIGURE # 17 REST OF THE WORLD RENAL REPLACEMENT THERAPY MARKET RESEARCH AND ANALYSIS, 2017-2023 ($ MILLION)
目次
Product Code: OMR2019492

Renal replacement therapy is the process of replacement of normal blood filtering mechanism of the kidney. The therapy is suggested when the kidneys are not working properly or are permanently damaged. The most probable treatment under renal replacement therapy includes dialysis, hemofiltration, and hemodiafiltration. The prevalence of kidney diseases and rising diabetic population is the major driver propelling the growth of this market. The problem with kidney is mostly seen in the geriatric population or the person with smoking habits. The increase in geriatric population and rise in a number of smokers is yet another factor contributing to the growth of the market.

However, the lack of infrastructure for therapies and inexperienced professional are the major restraining factors for the market growth. The therapies require lifelong checkup and treatment in some cases making it difficult for the patient to endure such long tenure of treatment. Moreover, increasing government expenditure and investment for the development of dialysis products will create an opportunity for the growth of the market during the forecast period.

The market is geographically divided into North America, Europe, Asia-Pacific and Rest of the World geographically. North America and Europe commutatively hold the major market share due to the presence of a large number of companies in the region. The regions also incorporate well-established healthcare facilities enabling proper therapies of the patients. The Asia-Pacific region is expected to experience significant growth in renal replacement therapy market during the forecasted period due to the rise in a number of kidney-related problems and growing healthcare infrastructure in the region.

The company engaged in renal replacement therapy market provides various types of devices for hemodialysis and peritoneal dialysis. Some of the key players operating in the renal replacement therapy market include Asahi Kasei Corporation., Baxter International Inc., Angiodynamics Inc., B. Braun Belsungen AG, C. R. Bard, Inc., Cryolife, Inc., DaVita Inc., and others.

Research methodology

The market study of global renal replacement therapy market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Authentic Public Databases such as World Health Organization (WHO)
  • Whitepapers such as research papers and news blogs
  • Company websites and their product catalog.

The report is intended for researchers in the healthcare segment, emerging companies and researchers in the market, Investing companies, government organizations for overall market analysis and competitive analysis. The report provides in-depth analysis on market size, growth opportunity in the market, and product types. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market segmentation

Global renal replacement therapy market is segmented on the basis of various regions and segments:

  • 1. Global Renal Replacement Therapy Market Research and Analysis by Therapy type
  • 2. Global Renal Replacement Therapy Market Research and Analysis by Route
  • 3. Global Renal Replacement Therapy Market Research and Analysis by End-user
  • 4. Global Renal Replacement Therapy Market Research and Analysis by Region

THE REPORT COVERS:

  • Comprehensive research methodology of global renal replacement therapy market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global renal replacement therapy.
  • Insights about market determinants which are stimulating the global renal replacement therapy.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography
    • 1.2.3. By Stakeholders

2. Market Overview and Insights

  • 2.1. Definition
  • 2.2. Analyst Insights & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendation
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Market Determinants

  • 3.1. Motivators
    • 3.1.1. Increase in Incidence of Kidney Related Diseases
    • 3.1.2. Large Number of Smokers in All Age Groups
    • 3.1.3. Exponential Growth Trend in Diabetic Population
    • 3.1.4. Increasing Product Launch
  • 3.2. Restraints
    • 3.2.1. Inexperienced Professionals Leading to Complexities
    • 3.2.2. Lack of Infrastructures for Therapies
  • 3.3. Opportunities
    • 3.3.1. Government Expenditure in Healthcare Sector
    • 3.3.2. Investment for The Development of Dialysis Products

4. Market Segmentation

  • 4.1. Global Renal Replacement Therapy Market by Therapy Type
    • 4.1.1. Dialysis
      • 4.1.1.1. Hemodialysis
      • 4.1.1.2. Peritoneal Dialysis
    • 4.1.2. Hemofiltration
    • 4.1.3. Hemodiafiltration
    • 4.1.4. Kidney Transplantation
  • 4.2. Global Renal Replacement Therapy Market by Route
    • 4.2.1. Arteriovenous Route
    • 4.2.2. Venovenous Route
  • 4.3. Global Renal Replacement Therapy Market by End-User
    • 4.3.1. Hospitals and Clinics
    • 4.3.2. Research Institutes

5. Competitive Landscape

  • 5.1. Key Company Analysis
  • 5.2. Key Strategy Analysis

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Spain
    • 6.2.4. France
    • 6.2.5. Italy
    • 6.2.6. RoE
  • 6.3. Asia-Pacific
    • 6.3.1. India
    • 6.3.2. China
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of The World

7. Company Profiles

  • 7.1. Asahi Kasei Corp.
  • 7.2. AngioDynamics, Inc.
  • 7.3. B. Braun Melsungen AG
  • 7.4. Baxter International Inc.
  • 7.5. C. R. Bard, Inc.
  • 7.6. CryoLife, Inc.
  • 7.7. DaVita Inc.
  • 7.8. Diaverum Deutschland GmbH
  • 7.9. Fresenius Medical Care AG & Co. KGaA
  • 7.10. Hebei Ziweishan Pharmaceutical Co., Ltd.
  • 7.11. Isopure Corp.
  • 7.12. JMS Co., Ltd.
  • 7.13. Kawasumi Laboratories, Inc.
  • 7.14. Medivators Inc.
  • 7.15. Medtronic PLC
  • 7.16. Navilyst Medical, Inc.
  • 7.17. Nikkiso Co. Ltd.
  • 7.18. NxStage Medical, Inc.
  • 7.19. Renacon Pharma Ltd.

7.20.Rockwell Medical, Inc.

Back to Top